Recorded Chinese product: 盐酸洛美沙星片盐酸洛美沙星片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
批准文号:NMPA approval number: 国药准字H10970009
生产企业Manufacturer
- 山东鲁抗医药集团赛特有限责任公司Chinese legal name: 山东鲁抗医药集团赛特有限责任公司
主要成分Active Ingredients
- 洛美沙星Luomei Shaxing
药物知识说明
国药准字H10970009是一种在国家药监局注册认定的药品。该药品含有洛美沙星-37120100等成分。
该药品关联的活性成分包括：洛美沙星Luomei Shaxing。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：山东鲁抗医药集团赛特有限责任公司Chinese legal name: 山东鲁抗医药集团赛特有限责任公司。
您可以探索含有相同成分的其他药品：洛美沙星-37120100成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盐酸洛美沙星片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 洛美沙星Luomei Shaxing.
Manufacturers recorded for this product: 山东鲁抗医药集团赛特有限责任公司Chinese legal name: 山东鲁抗医药集团赛特有限责任公司.
Explore other medicines containing the same ingredient: 洛美沙星 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盐酸洛美沙星片Recorded Chinese product: 盐酸洛美沙星片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.1g(以C17H19F2N303计)Recorded Chinese specification
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 山东鲁抗医药集团赛特有限责任公司Chinese legal name: 山东鲁抗医药集团赛特有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10970009
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10970009
Manufacturer
Chinese legal name: 山东鲁抗医药集团赛特有限责任公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10970009
生产企业
山东鲁抗医药集团赛特有限责任公司(国产)
适应症
适用于敏感细菌引起的轻中度感染:|1.下呼吸道感染:慢性支气管炎急性发作、支气管扩张伴感染、急性支气管炎、肺炎等。|2.泌尿生殖系统感染:急性膀胱炎、急性肾盂肾炎、复杂性尿路感染、慢性尿路感染急性发作、急慢性前列腺炎、单纯性淋病等。|3.腹腔胆道、肠道、伤寒等感染。|4.皮肤软组织感染。|5.其它感染,如副鼻窦炎、中耳炎、眼睑炎等
用法用量
口服:一日0.6g,分2次服；病情较重者可增至一日0.8g,分2次服。|1.单纯性尿路感染:一次0.4g,一日1次。|2.单纯性淋病:一日0.6g,分2次口服,或遵医嘱。
不良反应
个别患者可出现中上腹部不适、纳差、恶心、口干、轻微头痛、头晕等症状，偶可出现皮疹、皮肤瘙痒等过敏反应和心悸、胸闷等，偶有谷草转氨酶、谷丙转氨酶升高等。
禁忌
对本品或其他氟喹诺酮类药物过敏者禁用。
注意事项
1.肾功能减退者慎用。|2.肝功能不全者慎用，若使用，应注意监测肝功能。
贮藏
遮光，密封保存。
规格
0.1g(以C17H19F2N303计)
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.